to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
A healthcare VC predicts that more DNA sequencing and the shift from patients to healthcare consumers, among other things, will rule the future of healthcare innovation.
Security for mobile medical devices is key in the healthcare industry. Read more for tips on keeping healthcare data secure.
Creating useful web and mobile health solutions for patients is important at a time when so many consumers are using smartphones to access the web. Read about tips on making your health app a success.
At age 25, Laura Sanko was a founding member of a startup that raised $3.5 Million from some world-famous investors and the Founder’s Fund. The business model was simple: a website that rented high-end jewelry for special occasions for a fraction of the retail value of each piece. Three years later, the investment money was all gone and while the site continued to operate, it had failed to meet the investors’ expectations.
One way for life science and digital health entrepreneurs to innovate: turn landmark literature into accessible, web-based programs.
That’s what Omada Health, a San Francisco startup, has done for diabetes prevention. In a session on the future of intervention at the FutureMed conference at Singularity University in the Silicon Valley last week, the company’s co-founder and CEO Sean Duffy explained the effort.
DioGenix, in Gaithersburg, Md., was founded in 2009 after CEO Larry Tiffany and his senior management team saw a clear clinical need: monitoring disease progression of multiple sclerosis (MS). Tiffany has an extensive background in biotech, as an IP attorney, and as a senior executive at small and mid-size biotech companies. Before DioGenix, he was senior vice president and general manager of genomics for another genomics research company, Gene Logic.
Dr. Todd O’Brien has additional challenges beyond those encountered by most startup life science CEOs. The 48-year-old podiatrist still sees patients even while developing his latest innovation: an electronic tuning fork for measuring diabetes-related nerve damage in people’s feet. He's also building his company in Orono, Maine - far from any major healthcare hub.
The team at Ginger.io, a Cambridge, Mass.-based health data company, had a great product: a behavior analytics platform using smartphone data to create health insights. But they needed a clinical partner to help get access to patients and physicians. That’s where C3N came in.
Join the conversation this week with eMed's entrepreneurs to follow on twitter.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.